- Home
- NTRP vs BRTX Comparison
NTRP vs BRTX Comparison
Compare NTRP & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRP
- BRTX
- Stock Information
- Founded
- NTRP 1985
- BRTX 1997
- Country
- NTRP United States
- BRTX United States
- Employees
- NTRP N/A
- BRTX N/A
- Industry
- NTRP
- BRTX Managed Health Care
- Sector
- NTRP
- BRTX Health Care
- Exchange
- NTRP NYSE
- BRTX Nasdaq
- Market Cap
- NTRP 12.7M
- BRTX 13.7M
- IPO Year
- NTRP N/A
- BRTX N/A
- Fundamental
- Price
- NTRP $2.10
- BRTX $1.80
- Analyst Decision
- NTRP Hold
- BRTX Strong Buy
- Analyst Count
- NTRP 1
- BRTX 1
- Target Price
- NTRP $5.00
- BRTX $18.00
- AVG Volume (30 Days)
- NTRP 295.1K
- BRTX 27.8K
- Earning Date
- NTRP 06-10-2025
- BRTX 05-14-2025
- Dividend Yield
- NTRP N/A
- BRTX N/A
- EPS Growth
- NTRP N/A
- BRTX N/A
- EPS
- NTRP N/A
- BRTX N/A
- Revenue
- NTRP $501,422.00
- BRTX $391,000.00
- Revenue This Year
- NTRP $354.28
- BRTX $446.88
- Revenue Next Year
- NTRP $536.37
- BRTX N/A
- P/E Ratio
- NTRP N/A
- BRTX N/A
- Revenue Growth
- NTRP 186.93
- BRTX 161.54
- 52 Week Low
- NTRP $1.39
- BRTX $1.03
- 52 Week High
- NTRP $8.50
- BRTX $2.55
- Technical
- Relative Strength Index (RSI)
- NTRP 41.73
- BRTX 56.92
- Support Level
- NTRP $1.72
- BRTX $1.68
- Resistance Level
- NTRP $2.21
- BRTX $1.79
- Average True Range (ATR)
- NTRP 0.22
- BRTX 0.08
- MACD
- NTRP 0.07
- BRTX 0.02
- Stochastic Oscillator
- NTRP 49.35
- BRTX 77.14
About NTRP NEXTTRIP INC
NextTrip Inc is a technology-driven platform delivering travel booking and travel media solutions. It provides individual and group travelers with vacations to popular and sought-after destinations in Mexico, the Caribbean, and across the world. NextTrip Media platform - Travel Magazine offers a social media platform for viewers to explore, educate, and share with friends their bucket list travel. The company is also launching an end-to-end content ecosystem that uses AI-assisted travel planning capturing advertising, building brand awareness, rewarding loyalty, and driving bookings.
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.